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Dear editor,
Apoptosis is a fundamental biochemical cell-death pathway 
that plays important roles in various physiological and patho-
logical processes during fetal development and in adult tissues.
1 
In the intrinsic pathway, a number of death stimuli engage the 
apoptotic machinery by causing release of cytochrome c from 
mitochondria, which in turn induces recruitment of caspase-9 
into an apoptosome.
1 Activated caspase-9 initiates a proteo-
lytic cascade by activating effector caspases that cleave key 
molecules to induce apoptosis. As inactivation of pro-apoptotic 
genes through genetic alterations have been reported in many 
cancers, they are considered tumor suppressor genes.
2,3
Voltage-dependent anion channel 1 (VDAC1) is located in 
the outer mitochondrial membrane (OMM), and is involved in 
controlling metabolic cross-talk between mitochondria and the 
cytosol.
4 In addition, VDAC1 plays a key role during intrinsic 
apoptosis. VDAC1 constitutes an OMM channel that mediates 
the release of a number of apoptogenic molecules, including 
cytochrome c, second mitochondria-derived activator of caspase 
(Smac), HTRA serine peptidase 2 (HTRA2), apoptosis-inducing 
factor (AIF), and endonuclease G (EndoG) from mitochondria to 
the cytosol by OMM permeabilization.
4 VDAC1-deficient mito-
chondria from a mutant cell did not exhibit a Bax/Bak-induced 
loss in membrane potential of OMM and in cytochrome c re-
lease.
5 Since VDAC1 plays an important role in apoptosis sig-
naling, it could be hypothesized that VDAC1 gene is inactivated 
through somatic mutation in human cancers. To date, however, 
the data on the mutation status of VDAC1 in human cancers is 
lacking. 
By analyzing the public database (http://genome.cse.ucsc.
edu/), we found an A8 repeat in exon 6 of VDAC1 gene 
(nucleotides 325-332) that had not been analyzed for muta-
tions in cancers. Microsatellite instability (MSI) is defined by 
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length alterations in repeated DNA sequences, and 10% to 30% 
of colorectal cancer (CRC) and gastric cancer (GC) are classi-
fied as MSI-positive cancers.
6 To see whether the A8 repeat is 
mutated in GC and CRC with MSI, we performed polymerase 
chain reaction (PCR)-based single strand conformation poly-
morphism (SSCP). We analyzed 30 GC with high-MSI (MSI-H) 
and 10 GC with stable MSI (MSS), 37 CRC with MSI-H, and 14 
CRC with MSS according to the NCI criteria.
7 The GC consisted 
of 21 diffuse-type and 19 intestinal-type adenocarcinomas by 
Lauren’s classification. The TNM stages of the GC were 14 stage 
I, 16 stage II, 8 stage III, and 2 stage IV, while those of the CRC 
were 8 stage I, 18 stage II, 22 stage III, and 3 stage IV. Male to 
female ratios of gastric and colorectal cancers were 23:17 and 
30:21, respectively. All of the specimens were surgically re-
moved by gastrectomy and colectomy. Approval for this study 
was obtained from The Catholic University of Korea, College of 
Medicine’s Institutional Review Board.
Malignant cells and normal cells were selectively procured 
from hematoxylin and eosin-stained slides using a 30G1/2 hy-
podermic needle by microdissection as described previously.
2,3 
This microdissection method was proven to procure tumor cells 
with nearly being devoid of normal cell contamination.
2,3 DNA 
from tumor and normal cells were amplified by PCR using a 
primer pair that could amplify the A8 (product size 128 bps). 
Radioisotope ([
32P]dCTP) was incorporated into the PCR for de-
tection by SSCP. After SSCP, mobility shifts compared to wild-
type bands were analyzed by visual inspection. Direct DNA 
sequencing was performed in the cancers with mobility shifts 
in the SSCP. We repeated the experiments twice to ensure the 
specificity of the results.
PCR-SSCP analysis identified aberrant bands in one of the 
GC with MSI-H (1/30, 3.3%) and one of the CRC with MSI-H 
(1/37, 2.7%), but not in those with MSS. DNA from normal tis-Yoo NJ, et al: VDAC1 in Gastric and Colon Cancers  549
sue showed no shifts in SSCP, indicating the mutations had 
risen somatically. Direct DNA sequencing of the cancers with 
the aberrant bands led to identification of a recurrent VDAC1 
mutation in the A8 repeat sequence (Fig. 1). This mutation, 
c.332delA, leads to a premature stop codon, resulting in trunca-
tion of the amino acid synthesis (p.Asn111MetfsX34). The SSCP 
and DNA sequencing patterns indicate that the mutation was 
heterozygous (Fig. 1). There was no significant difference of the 
mutations with respect to the clinicopathologic features of the 
GC and CRC (Fisher’s exact test, p>0.05).
Earlier studies showed that VDAC1 exists as oligomers of 
varying sizes in the cells.
4,8 Mader et al.
8 demonstrated that a 
VDAC1 mutant bound with wild-type VDAC1 displayed a dom-
inant-negative effect in the intrinsic apoptosis pathway. The 
frameshift mutation of VDAC1 identified in this study would 
lead to a premature stop of amino acid synthesis in VDAC1 pro-
tein (p.Asn111MetfsX34) and would remove about 60% length 
of C-terminal VDAC1 protein. In this case, it is possible that the 
hemizygously mutated VDAC1 may bind with normal VDAC1 
to construct a structurally abnormal oligomer. As a possible 
mechanism of apoptosis inactivation in human cancers, we 
analyzed VDAC1 mutation in GC and CRC with MSI, and we 
identified for the first time a frameshift mutation in human can-
cer. To our knowledge, there has been no report on functions of 
VDAC1 protein related to MSI. To address consequences of such 
down-regulations in cancer development (especially related to 
cancers with MSI-H), additional functional studies on the mu-
tated gene should be performed. Although we identified somatic 
mutations of VDAC1 in both GC and CRC, the incidence was 
not high. To see whether other mechanisms of VDAC1 inactiva-
tion are present in these cancers, characterization of additional 
somatic alterations in VDAC1 should be undertaken. Antibody 
activity against frameshift neopeptides provides a promising 
tool for diagnostic application in MSI cancer patients. It might 
be clinically significant to analyze the immunogenic behavior 
of the VDAC1 neopeptides in future studies.
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Fig. 1. Frameshift mutations of VDAC1 in a gastric cancer and a 
colonic cancer with microsatellite instability. Direct DNA sequencing 
analyses of VDAC1 exon 6 from a gastric adenocarcinoma (A) and a 
colonic adenocarcinoma (B) with MSI-H show heterozygous A dele-
tion in tumor tissues compared with normal tissues.